This increase in COX-2 has been shown to enhance tumor progression through increased apoptosis resistance and increased metastatic properties (Choi et al., 2005; Singh et al., 2007; Karavitis and Zhang, 2013). This evidence concerns the gene PTGS2 and neoplasm.